Belen Aparicio
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies.
Journal: Human vaccines & immunotherapeutics
Published: February 12, 2024
Mutated trimeric RBD vaccines: a platform against variants of concern.
Journal: Signal transduction and targeted therapy
Published: March 10, 2023
Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.
Journal: Frontiers in immunology
Published: February 23, 2023
Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.
Journal: Frontiers in immunology
Published: September 14, 2022
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer.
Journal: Frontiers in immunology
Published: July 04, 2022
Ba+2 ion trapping using organic submonolayer for ultra-low background neutrinoless double beta detector.
Journal: Nature communications
Published: February 10, 2022
Neoantigens as potential vaccines in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: January 26, 2022
Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
Journal: International journal of molecular sciences
Published: January 18, 2022
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Journal: Emerging microbes & infections
Published: September 20, 2021
Last Updated: 09/26/2026